royalty deal

Advertisement

cGxPJobs Banner

BridgeBio Secures $300 Million Upfront Through Royalty Monetization of BEYONTTRA in Europe

PALO ALTO, CA., June 30, 2025 — BridgeBio Pharma, Inc. (Nasdaq: BBIO), the biopharmaceutical company dedicated to developing transformative...

By cGxPwire Editor
August 25, 2025

Read More

Advertisement

cGxPJobs

Directory